tradingkey.logo

tradingkey.logo
怜玢


Imunon Inc

IMNN
りォッチリストに远加
0.629USD
-0.008-1.26%
終倀 11-13 16:00ET
3.53M時䟡総額
損倱額盎近12ヶ月PER

Imunon Incに぀いお 䌁業名

Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Imunon Inc プロフィヌル


䌁業コヌドIMNN
䌚瀟名Imunon Inc
䞊堎日Oct 27, 1993
最高経営責任者「CEO」Lindborg (Stacy R)
埓業員数25
蚌刞皮類Ordinary Share
決算期末Oct 27
本瀟所圚地997 Lenox Dr Ste 100
郜垂LAWRENCEVILLE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号08648
電話番号16098969100
りェブサむトhttps://imunon.com/
䌁業コヌドIMNN
䞊堎日Oct 27, 1993
最高経営責任者「CEO」Lindborg (Stacy R)

Imunon Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
127.46K
+7.82%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Chief Executive Officer, President and Director
Chief Executive Officer, President and Director
121.66K
+3.13%
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
76.36K
+2.09%
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
35.06K
+37.55%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
27.25K
+43.11%
Ms. Christine A. Pellizzari
Ms. Christine A. Pellizzari
Independent Director
Independent Director
27.21K
+48.39%
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
21.04K
+0.06%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
3.65K
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel and Corporate Secretary
General Counsel and Corporate Secretary
2.90K
-87.74%
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
127.46K
+7.82%
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
Chief Executive Officer, President and Director
Chief Executive Officer, President and Director
121.66K
+3.13%
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
76.36K
+2.09%
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
35.06K
+37.55%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
27.25K
+43.11%
Ms. Christine A. Pellizzari
Ms. Christine A. Pellizzari
Independent Director
Independent Director
27.21K
+48.39%

よくある質問

Imunon Incの䞊䜍5名の株䞻は誰ですか


Imunon Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Michael H. Tardugno

Imunon IncIMNNの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Imunon Incの株匏を保有しおいる機関は46瀟あり、保有株匏の総垂堎䟡倀は玄431.10Kで、党䜓の10.82%を占めおいたす。2025Q4ず比范しお、機関の持ち株は47090.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。